Malaysia Oversight

Mawar Medical Centre posts RM4.34mil profit in FY2025

By NST in September 21, 2025 – Reading time 2 minute
Mawar Medical Centre posts RM4.34mil profit in FY2025


KUALA LUMPUR: Mawar Medical Centre (MMC) has reported a net profit of RM4.34 million for its financial year 2025, marking a major milestone in its growth since reopening in September 2019.

Speaking at the centre’s annual general meeting on Saturday, chairman Datuk Seri Lee Tian Hock said the hospital had achieved stable financial progress, with revenue rising 11.8 per cent to RM80.7 million from RM72.2 million in financial year 2024.

Average monthly revenue increased to RM6.7 million from RM6.0 million the previous year, reflecting an expanding patient base and enhanced service offerings.

While gross profit grew slightly to RM35.2 million, the gross profit margin narrowed from 47.9 per cent to 43.6 per cent, largely due to rising operational costs.

Its operating profit, excluding management fees to Matrix Medicare Sdn Bhd, fell 9.4 per cent to RM12.6 million, although the hospital reduced its debt to MMSB from RM22.0 million to RM12.7 million.

MMC has steadily increased its capacity, from 28 beds in 2019 to 97 beds in the financial year 2025, with 84 operational beds on average.

The hospital now has 25 resident consultants, 41 visiting consultants, and 18 specialist outpatient clinics, including new disciplines such as medical oncology, neurology, gastroenterology and hepatology, paediatric dermatology, and cardiac electrophysiology.

Investments in infrastructure and advanced medical equipment reached RM9.4 million, supporting the hospital’s long-term sustainability and commitment to quality care.

MMC introduced several national and regional firsts in financial year 2025, including intravascular ultrasound and intravascular lithotripsy for advanced cardiac treatment, robotic-assisted total knee replacement using the Cori Robotic System, and multiple cases of endoscopic sleeve gastroplasty and transoral outlet reduction procedures for post-bariatric care.

The hospital’s achievements were recognised with several awards, including Best Cardiology Medical Centre and Best Orthopaedic Medical Centre in Seremban at the Natural Health Awards 2024, Best Private Hospital (Category) in Negeri Sembilan at the Malaysia Health & Wellness Brand Awards 2024, and the “Most Promising Company” accolade at the Anugerah Kecemerlangan Industri 2024.

Lee highlighted the hospital’s commitment to staff welfare, with a total of RM3.06 million in bonuses awarded in December 2024 and salary increments of up to 5.28 per cent for 291 employees in the financial year 2025.

Community service remained a priority, with RM906,000 disbursed in welfare subsidies and sponsorships for underprivileged patients. MMC also reinvested RM183,700 from operating surplus to benefit its 167 dialysis patients, providing each with RM1,100.

MMC plans to expand its capacity further with 12 new inpatient beds, 16 new daycare beds, a hybrid operating theatre, a third operating theatre, and 13 new specialist clinics in the financial year 2026.

A dedicated Health Screening Centre is also set to be launched.

MMC recently opened its new facilities, including a 13-room First Floor Specialist Clinic and a 12-bed Dahlia Ward on the second floor, as well as staff amenities such as a gymnasium and doctors’ lounge, enhancing patient care and employee well-being.

© New Straits Times Press (M) Bhd



Source link